ArticleAntimicrobial agents and chemotherapy2012

Feasibility of a fixed-dose regimen of pyrazinamide and its impact on systemic drug exposure and liver safety in patients with tuberculosis.

Tarjinder Sahota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.